The India diabetic foot ulcer treatment market size is expected to reach USD 361.2 million by 2030, registering a CAGR of 7.82% from 2024 to 2030. The market has been witnessing significant growth, driven by several factors such as the rising prevalence of diabetes, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and an aging population, which has led to an increase in the incidence of diabetic foot ulcers. With approximately 77 million diabetic patients in India, the demand for effective treatment options for diabetic foot ulcers is on the rise.
Additionally, increasing awareness about diabetic foot care among patients and healthcare professionals has contributed to the market growth. Moreover, advancements in medical technology and the introduction of innovative wound care products, such as advanced dressings, bioengineered skin substitutes, and growth factors, have improved the efficacy of diabetic foot ulcer treatment, further driving market growth. Furthermore, government initiatives to improve healthcare infrastructure and increase access to diabetic care services in rural areas are expected to bolster market expansion. Overall, the combination of these factors is propelling the market forward, with promising growth prospects in the forecast period.
Several diabetes care device manufacturers are setting up new manufacturing facilities in India owing to the favorable regulatory environment and high population. Several companies are entering into partnerships and collaborations to gain a competitive advantage. For instance, in October 2022, Healthium Medtech, a Bengaluru-based company, launched several wound dressing products under its wound care portfolio. These dressings are intended to cure venous leg ulcers and diabetic foot ulcers. Thus, such factors are expected to increase the competition in market.
Market players are constantly develop new and improved products to ensure quicker healing time for diabetic foot ulcers. Companies such as ConvaTec, Inc., Acelity L.P. Inc., 3M Healthcare, Coloplast Corp., and Smith & Nephew Plc., are among the leaders in this market. Additionally, increasing research and development and collaboration is also fueling the market growth. For instance, in March 2023, Mylab Discovery Solutions, a Pune-based biotechnology company, collaborated with a UK-based firm to develop a diabetic foot ulcer detection kit. This kit aims to provide a rapid and accurate diagnosis of diabetic foot ulcers, a common complication among diabetic patients that can lead to serious infections and amputations if not treated promptly. The partnership between Mylab and the UK firm leverages Mylab's expertise in molecular diagnostics and the UK firm's experience in diabetic foot ulcer management. The kit utilizes advanced technology to detect specific biomarkers associated with diabetic foot ulcers, enabling early intervention and improved patient outcomes. This development signifies a significant step forward in addressing the growing burden of diabetic foot ulcers in India and globally.
This product will be delivered within 1-3 business days.
Additionally, increasing awareness about diabetic foot care among patients and healthcare professionals has contributed to the market growth. Moreover, advancements in medical technology and the introduction of innovative wound care products, such as advanced dressings, bioengineered skin substitutes, and growth factors, have improved the efficacy of diabetic foot ulcer treatment, further driving market growth. Furthermore, government initiatives to improve healthcare infrastructure and increase access to diabetic care services in rural areas are expected to bolster market expansion. Overall, the combination of these factors is propelling the market forward, with promising growth prospects in the forecast period.
Several diabetes care device manufacturers are setting up new manufacturing facilities in India owing to the favorable regulatory environment and high population. Several companies are entering into partnerships and collaborations to gain a competitive advantage. For instance, in October 2022, Healthium Medtech, a Bengaluru-based company, launched several wound dressing products under its wound care portfolio. These dressings are intended to cure venous leg ulcers and diabetic foot ulcers. Thus, such factors are expected to increase the competition in market.
Market players are constantly develop new and improved products to ensure quicker healing time for diabetic foot ulcers. Companies such as ConvaTec, Inc., Acelity L.P. Inc., 3M Healthcare, Coloplast Corp., and Smith & Nephew Plc., are among the leaders in this market. Additionally, increasing research and development and collaboration is also fueling the market growth. For instance, in March 2023, Mylab Discovery Solutions, a Pune-based biotechnology company, collaborated with a UK-based firm to develop a diabetic foot ulcer detection kit. This kit aims to provide a rapid and accurate diagnosis of diabetic foot ulcers, a common complication among diabetic patients that can lead to serious infections and amputations if not treated promptly. The partnership between Mylab and the UK firm leverages Mylab's expertise in molecular diagnostics and the UK firm's experience in diabetic foot ulcer management. The kit utilizes advanced technology to detect specific biomarkers associated with diabetic foot ulcers, enabling early intervention and improved patient outcomes. This development signifies a significant step forward in addressing the growing burden of diabetic foot ulcers in India and globally.
India Diabetic Foot Ulcer Treatment Market Report Highlights
- Based on treatment, the biologics segment accounted for the largest revenue share in 2023 owing to its reduced wound healing time and increased platelet formation efficiency
- Based on ulcer type, the neuro-ischemic segment accounted for the largest revenue share in 2023
- Based on end-use, the hospital segment accounted for the largest revenue share in 2023, due to the increased adoption rate of treatment and highly experienced staff
- North America accounted for the largest revenue share in the market due to the presence of market players and improved treatment cost and reimbursement scenario
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope
Chapter 4. India Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis
Chapter 5. India Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis
Chapter 6. India Diabetic Foot Ulcer Treatment Market: End-use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ConvaTec, Inc.
- Acelity L.P. Inc.
- 3M Healthcare
- Coloplast A/S
- Smith & Nephew Plc.
- B. Braun Melsungen AG
- Medline Industries, Inc.
- Medtronic Plc.
- Organogenesis, Inc.
- Molnlycke Health Care AB
- BSN Medical GMBH
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 213.7 Million |
| Forecasted Market Value ( USD | $ 361.2 Million |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | India |
| No. of Companies Mentioned | 11 |
